Sistemas transdérmicos resistentes al abuso que contienen opioides
摘要
<p>The present invention relates to transdermal dosage form ( Fig. 1-3 ) comprising at least one activating agent and at least one inactivating agent. The dosage form ( Fig. 1-3 ) releases the inactivating agent upon disruption of the dosage form ( Fig. 1-3 ) thereby preventing or hindering misuse of the active agent contained in the dosage form ( Fig. 1-3 ).</p>
申请公布号
ES2546828(T3)
申请公布日期
2015.09.29
申请号
ES20100009943T
申请日期
2002.04.30
申请人
EURO-CELTIQUE S.A.
发明人
TAVARES, LINO;REIDENBERG, BRUCE E.;SACKLER, RICHARD S.;WRIGHT, CURTIS;ALFONSO, MARK A.;OSHLACK, BENJAMIN;CASSIDY, JAMES P.;CARPANZANO, ANTHONY E.;GULLAPALLI, RAMPURNA PRASAD;SHEVCHUK, IHOR